8-K - Femasys Inc. | StockGist

AI Analysis

AI-generated analysis. Always verify with the original filing.

Femasys Inc. appointed John Canning as Chief Operating Officer effective March 30, 2026, with a $450,000 base salary and 150,000-share inducement stock option grant.

Key Takeaways

1Femasys Inc. appointed John Canning, age 52, as COO effective March 30, 2026.

2Canning's prior roles: COO at Terumo Aortic (2017-2026), Bolton Medical (2003-2017), Medtronic (1999-2003).

3Annual base salary of $450,000; target bonus 40% of base salary.

4Inducement stock option for 150,000 shares at Nasdaq closing price on March 30, 2026; vests 25% annually over 4 years.

5Severance: 9 months base salary, COBRA if terminated without cause or for good reason.

6No family relationships, prior transactions, or arrangements with Canning.

Current Report Details

Event Type

Management Change

Other Event

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

| Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers | |---|---|

Management Change

$450.0K

8.01

| Other Events | |---|---| On April 1, 2026, the Company issued a press release announcing the appointment of Mr. Canning as its Chief Operating Officer. A copy

Other Event

9.01

| Financial Statements and Exhibits. | |---|---| (d) Exhibits. | Exhibit No. | Description | |---|---| | | | | 10.1 | Employment Agreement, dated as of March 30

Exhibits Only

Source Document

Executive & Director Changes

John Canning

Chief Operating Officer

Appointment

Effective: 2026-03-30

Exhibits (3)

10.1

EXHIBIT 10.1

8-K

99.1

EXHIBIT 99.1